glutathione adducts Proposed metabolism of MRL-A to form M10 and the adduct, Glutathione adducts of oxyeicosanoids -

420,421 Another limitation of CPPs is their limited clinical efficacy, often requiring high concentrations and doses to achieve a therapeutic effect, which can cause significant toxicity and side effects, hindering the development of clinical applications

Food and Drug Administration for the treatment of either known or suspected cyanide poisoning.[i] Cyanide (CN) can be released by virtually any material containing carbon and nitrogen when burned under high temperature and low oxygen conditions.[ii],[iii] There is high potential for CN toxicity at many fire scenes due to the increased use of synthetic materials that produce CN during combustion in closed-space fires.2,3 Moderate to high concentrations of cyanide can cause severe injury and death within minutes.[iv] Therefore Cyanide poisoning is a life-threatening situation that requires immediate medical attention

An additional medium change was then accompanied by the addition of toxic concentrations of either NFT (Fig

10.1038/sj.mp.4001897 68